502.6000 -8.50 (-1.66%)
NSE Aug 07, 2026 15:31 PM
Volume: 150.0K
 

502.60
-1.66%
Axis Direct
We expect the whole API industry to continue facing challenges due to a fall in realization as well as an increase in cost pressure. We foresee the situation to continue for the next 2-3 quarters and therefore recommend a HOLD rating on the stock with the target price of Rs 1,300/share.
Promoters pledged 5.54% of shares in last quarter. Total pledge stands at 37.11% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended